Work

Dehydrolithocholic acid–FBW7–c-Jun signaling in CD8⁺ T cell dysfunction in colorectal cancer

Year: 2026
Type: preprint
Abstract: Gut microbiota-derived bile acids can influence mucosal immunity, but their effects on antitumor CD8⁺ T cells in colorectal cancer (CRC) are not well defined. Targeted fecal bile-acid profiling identified dehydrolithocholic acid (DHLCA) as enriched in treatment-naive patients with CRC and associated with more advanced clinicopathologic features. In syngeneic tumor models, oral DHLCA accelerated tumor growth, whereas this effect was no longer evident after CD8⁺ T cell depletion. In primary mouse CD8⁺ T cells, DHLCA reduced proliferation, IFN-γ and GzmB production, and antigen-specific tumor-cell killing; activated human CD8⁺ T cells showed changes in the same direction. DHLCA lowered both Jun transcript abundance and c-Jun protein availability. Cycloheximide chase, proteasome inhibition, and immunoprecipitation experiments further showed faster c-Jun turnover together with increased FBW7-c-Jun association and c-Jun-associated ubiquitination. Loss of c-Jun was accompanied by reduced AP-1 activity, lower c-Jun occupancy at Gzmb and Ifng regulatory regions, and weaker TRE-dependent reporter activity. Enforced c-Jun expression partially restored CD8⁺ T cell effector function and antitumor activity despite continued DHLCA exposure. DHLCA also weakened tumor control during PD-1 blockade. These results link a microbiota-associated bile acid to impaired CD8⁺ T cell function through coordinated RNA-level and post-translational regulation of c-Jun.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7225864620
Cites: 32
Cited by:
Related to: 10